novo oral glp 1 With FDA approval of Wegovy pill, new era of GLP-1 weight loss drugs begins Novo Nordisk expands oral GLP-1

Convenient dosing Once-weekly injections for some GLP-1s mean fewer doses and easier routines

If widely adopted, oral GLP-1 therapies could reshape obesity treatment, making effective medications easier to use, distribute, and integrate into long-term care

Patients should be educated to report symptoms of thyroid dysfunction, including palpitations, tremor, heat intolerance, anxiety (suggesting hyperthyroidism), or fatigue, cold intolerance, and weight gain (suggesting hypothyroidism)

The recognised normal level of B12 in the UK is considerably lower than the normal levels accepted in other developed countries such as America, Canada and Japan